₁₈Toshifumi Hibi

Summary for 2004 [at-glance overview of Toshifumi Hibi work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Toshifumi Hibi. According to available data, in 2004 Toshifumi Hibi published at least 18 articles. This work was completed in collaboration with several authors including Ishii, Hiromasa and Suzuki, Hidekazu. Many other authors have collaborated with Toshifumi Hibi as well. There is no information about the funding or the grants awarded to support this work.

Toshifumi Hibi has rank 27 when compared to all other authors using the keyword Crohn Disease. Analysis of the article abstracts and the titles suggests that Toshifumi Hibi professional interests are focused around "modified brown method", "active crohn disease" and "inflammatory bowel disease". These might also be referred to as "crohn disease", "human liver" or "hepatitis virus". Statistical analysis shows that Toshifumi Hibi's writing is likely to contains terms "cells", "patients", "liver", "disease", "hepatitis" and "human".

The affiliation of Toshifumi Hibi is uncertain, but might be related to Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160-8582, Japan. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Toshifumi Hibi]

Do you know Toshifumi Hibi who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Toshifumi Hibi]

₉₀Hibi, T

Year 2004 Charts [Toshifumi Hibi frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Toshifumi Hibi publication and funding history for the range of years]

Emails (5) [email addresses extracted from Toshifumi Hibi affiliations]

hidden to prevent spam, click here to reveal

Toshifumi Hibi Coauthors (80) [all coauthors with the number of joint publications]

8

4

3

3

3

3

2

₂₆Matsumoto, Takayuki

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

₁₂Kishimoto, Tadamitsu

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (11) [condensed summary of the Toshifumi Hibi affiliations, the leading number and the color conveys importance]

₆Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160-8582, Japan.
₂Department of Internal Medicine, Tokyo Dental College, Chiba Hospital, Chiba 261-8502, Japan.
₁Electron Microscopy Laboratory, Keio University, Tokyo, Japan.
₁Department of Gastroenterology, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, 663-8501, Japan.
₁Department of Internal Medicine, Eiju General Hospital, 2-23-16 Higashiueno, Taitoh-ku, Tokyo 110-8684, Japan.
₁Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
₁Department of Internal Medicine, Nippon-Koukan Hospital.
₁Department of Molecular Medicine, Graduate School of Medicine, Osaka University, Suita,
₁Department of Internal Medicine, Keio University School of Medicine.
₁Department of Radiology, Keio University School of Medicine.
₁Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine, Yamaguchi, Japan.

Key Opinion Leader In [Toshifumi Hibi is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂₇Crohn Disease | ₃₃Monocytes | ₃₃Colitis, Ulcerative | ₄₇₄Immunohistochemistry

Keywords (32) [keywords assigned to Toshifumi Hibi articles by PubMed, the leading number and the color conveys importance]

₁₃Humans | ₉Female | ₉Male | ₆Animals | ₆Middle Aged | ₄Crohn Disease | ₄Immunohistochemistry | ₄Rats | ₄Adult | ₃Adolescent | ₃RNA, Messenger | ₃Monocytes | ₃Colitis, Ulcerative | ₃Treatment Outcome | ₂Cytokines | ₂Child | ₂Biological Markers | ₂Gastric Mucosa | ₂Case-Control Studies | ₂Japan | ₂Granulocytes | ₂Polymerase Chain Reaction | ₂Tumor Necrosis Factor-alpha | ₂Reverse Transcriptase Polymerase Chain Reaction | ₂Adrenal Cortex Hormones | ₂Mice | ₂Biopsy | ₂Antibodies | ₂Liver | ₂Antibodies, Monoclonal | ₁Colon | ₁beta-Defensins

Toshifumi Hibi Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Toshifumi Hibi might be a good expert witness on these terms]

₃₇cells | ₂₄patients | ₂₁liver | ₁₇disease | ₁₅hepatitis | ₁₃human | ₁₂study | ₁₂role | ₁₂cancer | ₁₁mice | ₁₁gcap | ₁₁infection | ₁₁alcoholic | ₁₀gastric | ₁₀chronic | ₁₀cell | ₁₀therapy | ₉icos | ₉rats | ₉crohn | ₉hcv | ₉method | ₉hbd-2 | ₈ibd | ₈mucosal | ₈methods | ₈intestinal | ₈significantly | ₈leptin | ₇hepatocytes | ₇cd | ₇molecular
₉crohn disease | ₇human liver | ₆hepatitis virus | ₆alcoholic liver | ₆lamina propria | ₅liver injury | ₅ulcerative colitis | ₅barium enema | ₅gastric mucosal | ₅viral hepatitis | ₅inflammatory bowel | ₅brown method | ₅modified brown | ₄molecular clone | ₄bowel disease | ₄pathophysiological role | ₄ibd patients | ₄monoclonal antibody | ₄heavy drinkers | ₄liver tissues | ₄pylori infection | ₄active crohn | ₃hcv molecular | ₃therapy patients | ₃oral intestinal | ₃useful alternative | ₃infectious molecular | ₃lavage solution | ₃alternative therapy | ₃liver tissue | ₃steroid-refractory dependent | ₃intestinal lavage
₅modified brown method | ₄active crohn disease | ₄inflammatory bowel disease | ₄human liver tissues | ₄islet beta cells | ₃receptor monoclonal antibody | ₃preparation barium enema | ₃hepatitis virus infection | ₃intestinal lavage solution | ₃oral intestinal lavage | ₃infectious molecular clone | ₃human liver tissue | ₃alternative therapy patients | ₃useful alternative therapy | ₃lamina propria cells | ₃alcoholic liver disease | ₃nod scid mice | ₃derived balb mice | ₃actin filaments around | ₃directly induce apoptosis | ₃lymph nodes eradicate | ₃cell lymphoma cells | ₃heavy drinkers chronic | ₃hcc heavy drinkers | ₂ii ratio--a possible | ₂monocyte apheresis refractory | ₂granulocyte monocyte apheresis | ₂macrophage migration inhibitory | ₂adsorptive granulocyte monocyte | ₂lavage solution gastrointestinal | ₂efficacy administration oral | ₂virus infection human

Reader's Comments (0) [comments posted by readers of Toshifumi Hibi profile]